End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 25 | Soligenix Extends Patent Protection for Its Filovirus Vaccine Platform to the United Kingdom and South Africa | CI |
Apr. 15 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Chart calendar Soligenix Inc
Upcoming events on Soligenix Inc
Past events on Soligenix Inc
2024-03-15 07:30 am | Q4 2023 Earnings Release |
2024-02-20 | RedChip Investor Group Call |
2024-01-29 | Microcap Conference |
2024-01-25 09:30 am | Sequire Investor Summit |
2023-12-15 09:00 am | Annual General Meeting |
2023-11-13 07:30 am | Q3 2023 Earnings Release |
2023-10-18 | ThinkEquity Conference |
2023-08-21 07:30 am | Q2 2023 Earnings Release |
2023-05-15 07:30 am | Q1 2023 Earnings Release |
2023-03-31 07:30 am | Q4 2022 Earnings Release |
2023-02-08 09:00 am | Extraordinary Shareholders Meeting |
2023-01-26 09:00 am | Virtual Investor Summit |
2022-12-05 11:00 am | RHK Capital Disruptive Growth Conference |
2022-11-14 03:00 pm | FY Investor Summit |
2022-11-10 07:30 am | Q3 2022 Earnings Release |
2022-10-19 09:00 am | Annual General Meeting |
2022-09-12 07:00 am | H.C. Wainwright Global Investment Conference |
2022-08-17 09:00 am | Emerging Growth Conference |
2022-08-12 07:30 am | Interim 2022 Earnings Release |
2022-05-24 07:00 am | H.C. Wainwright Global Life Sciences Investment Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4,60 3,79 21.44% | 2,40 2,20 9.25% | 0,80 0,72 10.42% | 0,90 0,79 13.71% | 0,84 0,80 5.25% | 0,80 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -10,5 -10,0 -4.9% | -13,6 -14,1 3.69% | -13,1 -12,2 -7.64% | -14,2 -13,9 -2.68% | -7,70 -7,44 -3.47% | -8,20 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,97 -9,90 -0.65% | -18,5 -15,4 -19.95% | -13,4 -12,4 -8.19% | -15,0 -14,9 -0.36% | -7,91 -7,50 -5.45% | -8,60 |
Net income Million USD | Released Forecast Spread | -9,40 -9,29 -1.19% | -17,7 -14,4 -22.86% | -12,6 -12,2 -2.95% | -13,8 -14,0 1.13% | -6,14 -6,35 3.28% | -8,67 |
EPS USD | Released Forecast Spread | -7,20 -7,35 2.04% | -9,60 -8,03 -19.63% | -4,65 -4,58 -1.64% | -4,81 -4,80 -0.21% | -0,79 -0,83 4.24% | -0,63 |
Announcement Date | 30/03/20 | 30/03/21 | 29/03/22 | 31/03/23 | 15/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,25 0,20 25.7% | 0,20 0,10 100% | 0,40 0,20 100% | 0,17 0,20 -16.93% | 0,32 0,20 58.58% | 0,30 0,20 50% | 0,20 0,20 0% | 0,13 0,20 -34.78% | 0,24 0,20 22.41% | 0,20 | 0,20 | 0,20 | 0,20 |
EBIT Million USD | Released Forecast Spread | -4,52 -3,60 -25.64% | -4,20 -2,70 -55.65% | -3,40 -3,56 4.59% | -3,08 -3,42 10.01% | -3,57 -3,18 -12.35% | -2,15 -3,50 38.55% | -1,63 -3,01 45.77% | -1,78 -2,89 38.4% | -2,14 -1,86 -14.97% | -2,10 | -2,10 | -2,20 | -2,20 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,70 -3,70 -27.13% | -4,35 -2,80 -55.32% | -3,54 -3,10 -14.25% | -3,31 -3,30 -0.27% | -3,75 -3,70 -1.45% | -2,21 -3,60 38.69% | -1,61 -3,90 58.67% | -1,66 -4,30 61.33% | -2,43 -2,00 -21.33% | -2,10 | -2,10 | -2,20 | -2,20 |
Net income Million USD | Released Forecast Spread | -4,75 -3,69 -28.82% | -4,30 -2,80 -53.57% | -2,40 -3,72 35.41% | -3,31 -3,58 7.61% | -3,76 -3,34 -12.6% | -1,00 -3,60 72.22% | -1,60 -3,16 49.43% | -1,66 -3,10 46.29% | -1,82 -2,02 9.77% | -2,10 | -2,10 | -2,20 | -2,20 |
EPS USD | Released Forecast Spread | -1,65 -1,35 -22.22% | -1,50 -1,05 -42.86% | -0,90 -1,28 29.41% | -1,20 -1,35 11.11% | -1,24 -1,13 -10.22% | -0,36 -1,25 71.2% | -0,22 -0,38 42.11% | -0,16 -0,29 44.83% | -0,16 -0,20 17.95% | -0,19 | -0,15 | -0,16 | -0,16 |
Announcement Date | 29/03/22 | 13/05/22 | 12/08/22 | 10/11/22 | 31/03/23 | 15/05/23 | 21/08/23 | 13/11/23 | 15/03/24 | - | - | - | - |
Today 04:05 pm | EXELIXIS, INC.: Q1 2024 Earnings Release |
2024-04-30 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
2024-04-30 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-01 07:00 am | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-01 04:05 pm | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-01 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-01 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
2024-05-01 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for Soligenix Inc
- Stock Market
- Equities
- SNGX Stock
- Stock
- Calendar Soligenix Inc